Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

GHSI EMERGENCY RADIONUCLIDE BIOASSAY LABORATORY NETWORK - SUMMARY OF THE SECOND EXERCISE

C. Li, C. Bartizel, P. Battisti, A. Böttger, C. Bouvier, A. Capote-Cuellar, Z. Carr, D. Hammond, M. Hartmann, T. Heikkinen, RL. Jones, E. Kim, R. Ko, R. Koga, B. Kukhta, L. Mitchell, R. Morhard, F. Paquet, D. Quayle, P. Rulik, B. Sadi, A. Sergei,...

. 2017 ; 174 (4) : 449-456.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025316

The Global Health Security Initiative (GHSI) established a laboratory network within the GHSI community to develop collective surge capacity for radionuclide bioassay in response to a radiological or nuclear emergency as a means of enhancing response capability, health outcomes and community resilience. GHSI partners conducted an exercise in collaboration with the WHO Radiation Emergency Medical Preparedness and Assistance Network and the IAEA Response and Assistance Network, to test the participating laboratories (18) for their capabilities in in vitro assay of biological samples, using a urine sample spiked with multiple high-risk radionuclides (90Sr, 106Ru, 137Cs, and 239Pu). Laboratories were required to submit their reports within 72 h following receipt of the sample, using a pre-formatted template, on the procedures, methods and techniques used to identify and quantify the radionuclides in the sample, as well as the bioassay results with a 95% confidence interval. All of the participating laboratories identified and measured all or some of the radionuclides in the sample. However, gaps were identified in both the procedures used to assay multiple radionuclides in one sample, as well as in the methods or techniques used to assay specific radionuclides in urine. Two-third of the participating laboratories had difficulties in determining all the radionuclides in the sample. Results from this exercise indicate that challenges remain with respect to ensuring that results are delivered in a timely, consistent and reliable manner to support medical interventions. Laboratories within the networks are encouraged to work together to develop and maintain collective capabilities and capacity for emergency bioassay, which is an important component of radiation emergency response.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025316
003      
CZ-PrNML
005      
20180710093719.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/rpd/ncw254 $2 doi
035    __
$a (PubMed)27574317
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Li, Chunsheng $u Health Canada, Ottawa, Canada.
245    10
$a GHSI EMERGENCY RADIONUCLIDE BIOASSAY LABORATORY NETWORK - SUMMARY OF THE SECOND EXERCISE / $c C. Li, C. Bartizel, P. Battisti, A. Böttger, C. Bouvier, A. Capote-Cuellar, Z. Carr, D. Hammond, M. Hartmann, T. Heikkinen, RL. Jones, E. Kim, R. Ko, R. Koga, B. Kukhta, L. Mitchell, R. Morhard, F. Paquet, D. Quayle, P. Rulik, B. Sadi, A. Sergei, I. Sierra, W. de Oliveira Sousa, G. Szab,
520    9_
$a The Global Health Security Initiative (GHSI) established a laboratory network within the GHSI community to develop collective surge capacity for radionuclide bioassay in response to a radiological or nuclear emergency as a means of enhancing response capability, health outcomes and community resilience. GHSI partners conducted an exercise in collaboration with the WHO Radiation Emergency Medical Preparedness and Assistance Network and the IAEA Response and Assistance Network, to test the participating laboratories (18) for their capabilities in in vitro assay of biological samples, using a urine sample spiked with multiple high-risk radionuclides (90Sr, 106Ru, 137Cs, and 239Pu). Laboratories were required to submit their reports within 72 h following receipt of the sample, using a pre-formatted template, on the procedures, methods and techniques used to identify and quantify the radionuclides in the sample, as well as the bioassay results with a 95% confidence interval. All of the participating laboratories identified and measured all or some of the radionuclides in the sample. However, gaps were identified in both the procedures used to assay multiple radionuclides in one sample, as well as in the methods or techniques used to assay specific radionuclides in urine. Two-third of the participating laboratories had difficulties in determining all the radionuclides in the sample. Results from this exercise indicate that challenges remain with respect to ensuring that results are delivered in a timely, consistent and reliable manner to support medical interventions. Laboratories within the networks are encouraged to work together to develop and maintain collective capabilities and capacity for emergency bioassay, which is an important component of radiation emergency response.
650    12
$a biotest $7 D001681
650    _2
$a náhlé příhody $7 D004630
650    _2
$a lidé $7 D006801
650    _2
$a laboratoře $7 D007753
650    _2
$a plutonium $7 D011005
650    12
$a únik radioaktivních látek $7 D018788
650    12
$a radionuklidy $7 D011868
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bartizel, Christine $u Institut de Radioprotection et de Sûreté Nucléaire, Le Vésinet, France.
700    1_
$a Battisti, Paolo $u Institute of Radiation Protection, ENEA, Rome, Italy.
700    1_
$a Böttger, Axel $u Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety, Bonn, Germany.
700    1_
$a Bouvier, Céline $u Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France.
700    1_
$a Capote-Cuellar, Antonio $u International Atomic Energy Agency, Vienna, Austria.
700    1_
$a Carr, Zhanat $u World Health Organization, Geneva, Switzerland.
700    1_
$a Hammond, Derek $u Public Health England, Chilton, UK.
700    1_
$a Hartmann, Martina $u Bundesamt für Strahlenschutz, Berlin, Germany.
700    1_
$a Heikkinen, Tarja $u Radiation and Nuclear Safety Authority (STUK), Helsinki, Finland.
700    1_
$a Jones, Robert L $u Centers for Disease Control and Prevention, Atlanta, USA.
700    1_
$a Kim, Eunjoo $u National Institute of Radiological Sciences, Chiba, Japan.
700    1_
$a Ko, Raymond $u Health Canada, Ottawa, Canada.
700    1_
$a Koga, Roberto $u Instituto Peruano de Energia Nuclear, Lima, Peru.
700    1_
$a Kukhta, Boris $u State Research Center - Burnasyan Federal Medical Biophysical Center, Moscow, Russia.
700    1_
$a Mitchell, Lorna $u Public Health England, Glasgow, UK.
700    1_
$a Morhard, Ryan $u Department of Health and Human Services, Washington, DC, USA.
700    1_
$a Paquet, Francois $u Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France.
700    1_
$a Quayle, Debora $u Health Canada, Ottawa, Canada.
700    1_
$a Rulik, Petr $u National Radiation Protection Institute (SURO), Praha, Czech Republic.
700    1_
$a Sadi, Baki $u Health Canada, Ottawa, Canada.
700    1_
$a Sergei, Aleksanin $u All-Russian Center of Emergency & Radiation Medicine, St. Peterburg, Russia.
700    1_
$a Sierra, Inmaculada $u Centro de Investigaciones Energéticas, Medioambientales y Tecnol?gicas, Madrid, Spain.
700    1_
$a de Oliveira Sousa, Wanderson $u Comissão Nacional de Energia Nuclear, Rio de Janeiro, Brazil.
700    1_
$a Szab, Gyula $u National Public Health Center, Budapest, Hungary.
773    0_
$w MED00004029 $t Radiation protection dosimetry $x 1742-3406 $g Roč. 174, č. 4 (2017), s. 449-456
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27574317 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180710094009 $b ABA008
999    __
$a ok $b bmc $g 1317447 $s 1022237
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 174 $c 4 $d 449-456 $i 1742-3406 $m Radiation protection dosimetry $n Radiat Prot Dosimetry $x MED00004029
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace